Unmet needs in Parkinson’s disease: new horizons in a changing landscape
No Thumbnail Available
Authors
Chaudhuri, K. Ray
Bhidayasiri, Roongroj
van Laar, Teus
Contact
Check for full-text access
Issue Date
2016
Type
Article
Language
Keywords
Alternative Title
Abstract
The success of levodopa and other classes of drugs have meant that most people with Parkinson's disease enjoy a good quality of life for many years. However, despite the availability of several drugs and formulations that can be used as monotherapy and in combination, there are a number of disease features that the current therapies are unable to address. The disease continues to progress despite treatment, patients suffer from a myriad of motor and non-motor symptoms, and a neuroprotective therapy is urgently required. To move forward with medical and surgical management, it is important to consider new insights that recent research offers and in this review we examine how a better understanding of the disease pathology and progression might improve and enrich our daily clinical practice. It is also timely to consider the service provision changes that will increasingly be needed to effectively manage the needs of the aging population.
Description
Citation
Publisher
License
Journal
Parkinsonism & Related Disorders
Volume
33